Back
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.
Journal article

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.

  • Caers J Department of Hematology, University Hospital of Liege, Belgium jo.caers@chu.ulg.ac.be.
  • Garderet L Department of Hematology, Hopital Saint Antoine, Paris, France.
  • Kortüm KM Department of Internal Medicine II, University Hospital of Wuerzburg, Germany.
  • O'Dwyer ME Department of Hematology, National University of Ireland Galway, Ireland.
  • van de Donk NWCJ Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
  • Binder M Department of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dold SM Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Germany.
  • Gay F Department of Hematology-Oncology, University Hospital Città della Salute e della Scienza, Torino, Italy.
  • Corre J Unit for Genomics in Myeloma, Institut Universitaire du Cancer - Oncopole, Toulouse, France.
  • Beguin Y Department of Hematology, University Hospital of Liege, Belgium.
  • Ludwig H Wilhelminen Cancer Research Institute, Vienna, Austria.
  • Larocca A Department of Hematology-Oncology, University Hospital Città della Salute e della Scienza, Torino, Italy.
  • Driessen C Department of Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
  • Dimopoulos MA School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Boccadoro M Department of Hematology-Oncology, University Hospital Città della Salute e della Scienza, Torino, Italy.
  • Gramatzki M Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Germany.
  • Zweegman S Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
  • Einsele H Department of Internal Medicine II, University Hospital of Wuerzburg, Germany.
  • Cavo M Seragnoli 'Institute of Hematology, Bologna University School of Medicine, Italy.
  • Goldschmidt H Department of Hematology, Rheumatology and Oncology, University Hospital Heidelberg, Germany.
  • Sonneveld P Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Delforge M Department of Hematology, University Hospital Leuven, Belgium.
  • Auner HW Centre for Haematology, Hammersmith Hospital, Imperial College London, UK.
  • Terpos E School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Engelhardt M Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Germany.
Show more…
  • 2018-09-02
Published in:
  • Haematologica. - 2018
Multiple Myeloma
Practice Guidelines as Topic
English The diagnosis of multiple myeloma can be challenging, even for experienced physicians, and requires close collaboration between numerous disciplines (orthopedics, radiology, nuclear medicine, radiation therapy, hematology and oncology) before the final diagnosis of myeloma is made. The definition of multiple myeloma is based on the presence of clinical, biochemical, histopathological, and radiological markers of disease. Specific tests are needed both at presentation and during follow-up in order to reach the correct diagnosis and characterize the disease precisely. These tests can also serve prognostic purposes and are useful for follow-up of myeloma patients. Molecular analyses remain pivotal for defining high-risk myeloma and are used in updated patient stratifications, while minimal residual disease assessment via flow cytometry, molecular techniques and radiological approaches provides additional prognostic information on patients' long-term outcome. This pivotal information will guide our future treatment decisions in forthcoming clinical trials. The European Myeloma Network group updated their guidelines on different diagnostic recommendations, which should be of value to enable appropriate use of the recommendations both at diagnosis and during follow-up.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/139118
Statistics
Document views: 108 File downloads: